Udupi: In a unique initiative, Government High School, Avarse in Brahmavar, established the Bhujanga Shetty Sports Lab that ...

Aurobindo Pharma experienced a slight dip in Q4FY25 net profit, despite a revenue increase. However, the company saw ...

Aurobindo Pharma posted a marginal decrease in its net profit at ₹903 crore in the fourth quarter ended March 31, 2025.

Aurobindo Pharma's Q4 net profit remains flat at ₹903 crore; revenue rises 10.6% YoY to ₹8,382 crore with strong performance ...

Aurobindo Pharma's net profit declines slightly, but revenue and total expenses show significant growth in March quarter.

Aurobindo Pharma on Monday reported a marginal dip in its consolidated profit after tax to Rs 903 crore for the fourth ...

For the full year ended March 31, 2025, the company said its PAT rose 10 per cent to Rs 3,484 crore against Rs 3,169 crore in ...

Aurobindo Pharma reported a marginal 0.4% YoY dip in Q4FY25 PAT to Rs 903 crore, even as revenue rose 10.6% to Rs 8,382 crore ...

The eye of the beholder might land on the once beautiful evening gown splattered in paint or a fabric panel with part of the ...

On a fiscal year basis (FY25), Aurobindo Pharma’s PAT increased 10% y-o-y to ₹3,484 crore from ₹3,169 crore in FY24, showing better full year profitability. Annual income at the company also grew by a ...

Aurobindo Pharma reported a slight decline in its consolidated profit after tax to Rs 903 crore for the fourth quarter ended March 2025. Revenue grew to Rs 8,382 crore.